// App-Quantinova.ai

788 : Next-Generation Sequencing and Real-Time Quantitative PCR for Minimal Residual Disease (MRD) Detection Using the Immunoglobulin Heavy Chain Variable Region: A Methodical Comparison in Acute Lymphoblastic Leukemia (ALL), Mantle Cell Lymphoma (MCL) and Multiple Myeloma (MM)

Researchers

Presenter

  • Monika Bruggemann

Principal Investigators

  • Simone Ferrero

  • Malek Faham

  • Christiane Pott

  • Francois Pepin

  • Daniela Drandi

  • Luigia Monitillo

  • Antonio Palumbo

  • Roberto Passera

  • Mario Boccadoro

  • Victoria Carlton

  • Heiko Trautmann

Medical Centers

  • Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  • Division of Nuclear Medicine, Statistical Consultant, University of Torino, Torino, Italy

  • Myeloma Unit, Division of Hematology, University of Torino, AOU S. Giovanni Battista, Torino, Italy

Locations

  • Germany

  • Italy

Companies

  • Sequenta, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mantle cell lymphoma

  • Multiple Myeloma

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Immunoglobulin heavy-chain variable region gene

  • T cell receptor alpha locus

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • active comparator

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved